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Age-Related Inducibility of Carboxylesterases by the
Antiepileptic Agent Phenobarbital and Implications in Drug
Metabolism and Lipid Accumulation 1, ,2
Da Xiao, Yi-Tzai Chen, Dongfang Yang, and Bingfang Yan
Department of Biomedical Sciences, Center for Pharmacogenomics and Molecular Therapy
University of Rhode Island Kingston, RI 02881

Abstract
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Carboxylesterases (CES) constitute a class of hydrolytic enzymes that play critical roles in drug
metabolism and lipid mobilization. Previous studies with a large number of human liver samples
have suggested that the inducibility of carboxylesterases is inversely related with age. To directly
test this possibility, neonatal (10 days of age) and adult mice were treated with the antiepileptic
agent phenobarbital. The expression and hydrolytic activity were determined on six major
carboxylesterases including ces1d, the ortholog of human CES1. Without exception, all
carboxylesterases tested were induced to a greater extent in neonatal than adult mice. The
induction was detected at mRNA, protein and catalytic levels. Ces1d was greatly induced and
found to rapidly hydrolyze the antiplatelet agent clopidogrel and support the accumulation of
neutral lipids. Phenobarbital represents a large number of therapeutic agents that induce drug
metabolizing enzymes and transporters in a species-conserved manner. The higher inducibility of
carboxylesterases in the developmental age likely represents a general phenomenon cross species
including human. Consequently, individuals in the developmental age may experience greater
drug-drug interactions. The greater induction of ces1d also provides a molecular explanation to the
clinical observation that children on antiepileptic drugs increase plasma lipids.
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1. Introduction
Carboxylesterases (E.C.3.1.1.1) constitute a class of hydrolytic enzymes that play critical
roles in lipid mobilization [1], drug metabolism [1-3] and detoxification of
organophosphorus, carba-mate and pyrethroid insecticides [4, 5]. Those are major
insecticides used in agricultural and residential setting [6]. Based on chemical structures, it
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is estimated that ∼20% therapeutic agents undergo hydrolytic biotransformation [3].
Carboxylesterase activity is widely distributed in mammalian tissues, with the highest level
in liver microsomes. Without exceptions, all mammalian species express multiple forms of
carboxylesterases [7]. However, the total number of carboxylesterase genes varies markedly
from species to species. For example, the human genome has seven carboxylesterase genes
including a pseudogene [7, 8], whereas the mouse genome contains as many as twenty
carboxylesterase genes [7]. In addition, diverse forms of carboxylesterases from a single
gene are produced through mechanisms such as alternative splicing [2].
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Like many other drug-metabolizing enzymes, the expression of carboxylesterases is
regulated by age, hormones, disease mediators and therapeutic agents [5, 9-12]. For
example, interleukin-6, a proinflammatory cytokine, suppresses the expression of several
human carboxylesterases [9]. Likewise, lipopolysaccharide, a potent proinflammatory
stimulus, efficaciously down-regulates the expression of several mouse carboxylesterases
[13]. Importantly, the suppressed expression by inflammatory mediators causes profound
changes in cellular responsiveness to commonly used ester drugs. For example, pretreatment
with interleukin-6 significantly decreases the hydrolytic activation of the anticancer prodrug
irinotecan [9]. In some cases, the regulated expression of carboxylesterases occurs in a
species-dependent manner. For example, the synthetic glucocorticoid dexamethasone
slightly induces human carboxylesterases but suppresses several major rat carboxylesterases
[10]. Conversely, phenobarbital, an antiepileptic agent, induces carboxylesterases cross
species [14, 15].
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The regulation of carboxylesterase expression, in many cases, is likely achieved by
composite mechanisms. In both human and rodents, we have shown that age is a major
determinant in gaining hydrolytic capacity during the developmental stage [5, 11, 14]. In
humans, the developmental regulation consists of an early surge during the neonatal stage
and a subsequent incremental increase throughout the entire adolescence. Interestingly, it
has been reported that some ester drugs exhibit larger pharmacokinetic variation among
young patients [16-18]. The greater variability is likely attributed to interplay between
developmental and xenobiotic regulations. In support of this notion, the level of
carboxylesterases is correlated with age but only to a moderate extent [5, 11] and several
major antiepileptic drugs including pheno-barbital increased the hydrolysis of rufinamide to
a greater extent in children than adults [17].
This study was designed to test the hypothesis that the inducibility of carboxylesterases is
inversely related with age. To test this hypothesis, neonatal (10 days of age) and adult (10
weeks) mice were treated with phenobarbital and the expression of six major
carboxylesterases was determined. Without exceptions, phenobarbital caused greater
induction of carboxylesterases in neonatal mice. The induction was detected by RT-qPCR
and Western blotting. The induced carboxylesterases differed markedly in the hydrolysis of
several commonly used drugs and in the accumulation of neutral lipids.
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2.1. Chemicals and supplies
Aspirin, 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP), 4methylumbelliferylacetate, 1-naphthylacetate, Oil Red O, pregnenolone 16α-carbonitrile
(PCN) and Hanks balanced salt solution were purchased from Sigma (St. Louis, MO).
Clopidogrel bisulfate was purchased from ChemPacific (Baltimore, MD). Clopidogrel
carboxylate was purchased from Toronto Research Chemicals (Toronto, ON, Canada).
Dulbecco's modified eagle medium (DMEM) was purchased from Invitrogen (Carlsbad,
CA). The antibody against glyceradehyde-3-phosphate dehydrogenase (gapdh) was from
Abcam (Cambridge, UK). The goat anti-rabbit IgG conjugated with horseradish peroxidase
was from Pierce (Rockford, IL). Nitrocellulose membranes were from Bio-Rad (Hercules,
CA). Expression constructs were purchased from OriGene Technologies Inc (Rockville,
MD). Unless otherwise specified, all other reagents were purchased from Fisher Scientific
(Fair Lawn, NJ).
2.2. Animal treatment
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Mice (C56BL/6) were purchased from Charles River (Wilmington, MA) and bred in house.
Male neonates (10 days of age) or adult (10 weeks of age) were injected ip once daily with
phenobarbital or the same volume of saline for four days [19]. Neonates received
phenobarbital at a dose of 20 mg/kg/day, whereas adult mice received a dose of 80 mg/kg/
day. For TCPOBOP treatment, all mice received 1.5 mg/kg/day for consecutive four days.
For PCN, all mice received 20 mg/kg/day for consecutive four days. The livers were
harvested 24 h after the last injection. One part of the livers was immediately used for
preparing total RNA and the remaining part was frozen at −80°C for preparing S9 fractions
later. All mice were allowed free access to Purina Rodent Chow 5001 and water, and the use
of animals was approved by the Institutional Animal Care and Use Committee.
2.3. Native gel electrophoresis stained for carboxylesterase activity
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The mouse genome contains three times of carboxylesterase genes as the human genome
[7]. There are no specific substrates for each carboxylesterase. We have previously shown
that many carboxylesterases remain active in polyacrylamide gel [12]. Importantly,
carboxylesterases, even hydrolyzing the same substrate, can be electrophoretically separated
and individually determined for hydrolytic activity. Liver homogenates (10 μg) was
solubilized with 0.2% Lubrol and subjected to electrophoresis with a 3% acrylamide
stacking gel and a 7.5% acrylamide separating gel. After electrophoresis, the gels were
washed for 1 h in 100 mM potassium phosphate buffer (pH 6.5), followed by incubating in
the same buffer containing 1-naphthylacetate (5 mM) and 4-benzolamino-2,5dimethoxybenzenediazonium chloride hemi (zinc chloride) salt, usually termed Fast Blue
RR (0.4 mg/ml). Staining for carboxylesterases by this method is based on the formation of
a black, insoluble complex between the hydrolytic products and Fast Blue RR. Staining for
hydrolytic activity was also determined with 4-methylumbelliferylacetate (1 mM). In both
cases, the images were captured by Carestream 2200 PRO Imager.
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2.4. Reverse transcription-quantitative polymerase chain eaction (RT-qPCR)
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Total RNA (1 μg) was reverse-transcribed to synthesize cDNAs as described previously
[11]. cDNAs were then diluted 16 times and RT-qPCR was conducted with TaqMan Gene
Expression Assay (Applied Biosystems, Foster City, CA). The TaqMan probes were: ces1d
(Ces3), Mm00474816_m1; ces1e (Es22), Mm00504914_m1; ces1g (ces1),
Mm00491334_m1; ces2a (Ces6), Mm00731842_g1; ces2c (Ces2), Mm00524035_m1, and
ces2e (Ces5), Mm00555211_m1. Normalization of RT-qPCR was performed based on the
signal of gapdh mRNA (Mm99999915_g1); and selective samples were analyzed for the
level of RNA polymerase II mRNA (Mm00839502_m1) to confirm the normalization. The
PCR amplification was conducted in a total volume of 20 μl containing universal PCR
master mixture (10 μl), gene-specific TaqMan assay mixture (1 μl), and cDNA template (6
μl). Amplification and quantification were done with the Applied Biosystems 7500 RealTime PCR System.
2.5. Hydrolysis of 1-naphthylacetate, aspirin and clopidogrel
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Hydrolysis of 1-naphthylacetate was determined spectrophotometrically as described
previously [8]. Hydrolysis of aspirin and clopidogrel was determined as described elsewhere
[20]. Briefly, samples (20 μg) were prepared in 50 μl phosphate buffer (0.1 M, pH 7.4) and
then mixed with an equal volume of aspirin (usually 2 mM) in the same buffer. The
incubations lasted for 30 min and the reactions were terminated with 150 μl of acetonitrile
containing acetaminophen (5 mM) as the internal standard (IS). The reaction mixtures were
subjected to centrifugation for 15 min at 4°C (12,000 g). Hydrolysis of clopidogrel was
carried similarly as that of aspirin. Samples (20 μg) were prepared in 50 μl reaction buffer
Tris-HCl (50 mM, pH 7.4), mixed with an equal volume of clopidogrel (200 μM) in the
same buffer, and incubated at 37°C for 20 min. The reactions were terminated and
centrifuged as described for the hydrolysis of aspirin, however, naproxen (0.5 mM) served
the IS. The formation of the hydrolytic metabolites was determined by HPLC (Hitachi-300)
with a Chromolith SpeedROD column RP-18e (Merck, Germany). The supernatants (10-30
μl) of the reaction mixtures were injected and separated by an isocratic (for aspirin) or
gradient (clopidogrel) mobile phase. The isocratic mobile phase consisted of 12 % methanol
and 0.25 % acetate acid at pH 3.9. The gradient mobile phase consisted of 4-21%
acetonitrile (v/v) for the first 4 min and 2-70% for second 4 min. The flow rate for both
aspirin and clopidogrel was 2 ml/min and the metabolites were detected by a diode array
detector at 238 nm (salicylic acid) or 230 nm (clopidogrel carboxylate). All quantifications
were performed using peak area ratios and calibration curves generated from the
corresponding internal control.
2.6. Oil Red O staining
Cells (293T) from GenHunter Corporation (Nashville, TN) were transfected with a construct
encoding a mouse carboxylesterase or the corresponding vector. The transfected cells were
cultured in full DMEM medium for 24 h and then in fatty acid-rich but serum free medium
(BSA complexed palmitic acid, 0.2 mM) for 24 h. Cells were washed extensively PBS and
fixed with 4% paraformaldehyde for 20 min at room temperature. The fixed cells underwent
dehydration with 100% 1,2-propanediol, stained with pre-warmed Oil Red O for 1 h at 37°C
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and rinsed with 85% 1,2-propanediol. The cells were washed with distilled water and
visualized for red fluorescence microscopically. Alternatively, stained lipids were extracted
with isopropyl alcohol, and quantified spectrometrically at 510nm.
2.7. Other analyses
Protein concentrations were determined with BCA assay (Pierce) based on albumin
standard. Western blotting was performed as described previously [11] and the preparation
of antibodies were described elsewhere [15]. Data are presented as mean ± SD or mean ± SE
of at least three separate experiments, except where results of blots are shown in which case
a representative experiment is depicted in the figures. Statistical significance between two
means was made according to One-way ANOVA followed by a DUNCAN's multiple
comparison test (p < 0.05). Letters or lines combined with asterisks were used to indicate
data-points for the comparisons.

3. Results
3.1. Induction of carboxylesterases in neonates and adult mice
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In this study, we first tested whether neonates (10-day-old) and adult mice show similar
levels of induction of carboxylesterases and whether the induction occurs in an isoformdependent manner. Adult mice were dosed at 20 or 80 mg/kg/day whereas neonates were
given three dosing regimens: 20, 40, or 80 mg/kg/day. However, some or all neonates were
dead at higher dosing regimens. Adult mice, dosed at 20 mg/kg/day, did not cause evident
induction on the carboxylesterases examined. Therefore, the results were presented from
neonates treated with the 20 mg/kg/day regimen and adult mice treated with the 80
mg/kg/day dosing regimen. The induction was initially assessed by native gel
electrophoresis stained for carboxylesterase activity with 1-naphthylacetate or 4methylumbelliferylacetate as the substrate. To gain the molecular identity, six recombinant
mouse carboxylesterases were included in this study and used as references [1, 7, 14, 21]. As
shown in Fig. 1A (Left), carboxylesterases stained with 1-naphthylacetate detected
recombinant ces1d, ces1e, ces2c and ces2e (Fig. 1A). Ces1d produced the maximal staining
followed by ces2c, ces1e and ces2e. With 4-methylumbelliferylacetate as the substrate, four
recombinant carboxylesterases were detected as well (Fig. 1B). However, there were notable
differences. Ces1e hydrolyzed 1-naphthylacetate but not 4-methylumbelliferylacetate, and
the opposite was true with ces2a (Figs. 1A and B). In addition, ces2c showed higher activity
toward 4-methylumbelliferylacetate than ces1d, and this was reversed when 1naphthylacetate was used as the substrate. Interestingly, ces1g did not hydrolyze either
substrate. As described later, transfection of this carboxylesterase did produce a protein
detected by Western blotting.
Liver S9 fractions from adult mice produced seven recognizable bands and four of them
corresponded to ces1d, ces2a, ces2e and ces2c, respectively (Fig. 1). It appeared that ces1d
produced two closely migrated bands (upper and lower), although it can not be excluded that
these two bands represent distinct carboxylesterases. Nevertheless, the lower band was more
intensified than the upper band with 4-methylumbelliferylacetate as the substrate (Fig. 1B)
but the opposite was true when 1-naphthylacetate (Fig. 1A). Ces2c was markedly induced
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with both substrates in phenobarbital-treated adult mice. However, ces1d and one of the
identity-unknown bands (ces-x) were also evidently induced when 1-naphthylacetate was
used as the substrate (Fig. 1A). In contrast to the adult liver samples, neonatal samples
produced only three recognizable bands including ces1d, ces-x and ces2c. All of these
carboxylesterases were markedly induced by both substrates. Overall, the activity staining
experiments demonstrated that neonates, compared with adult mice, expressed lower levels
and fewer carboxylesterases. However, the magnitude of induction in neonates was
generally greater than that in adult mice, which was confirmed by Western blotting and RTqPCR as described below. Finally, ces1e was not detected in either neonatal or adult mouse
livers by the staining experiment, suggesting that this carboxylesterase does not hydrolyze 4methylumbelliferyl-acetate or 1-naphthylacetate (Fig. 1).
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It is well established that two major nuclear receptors supports the action of phenobarbital:
the constitutive androstane receptor and the pregnane X receptor [22]. To shed light on the
identity of the receptor(s) in supporting the induction of carboxylesterases by phenobarbital,
mice (neonatal and adult) were treated with receptor-specific activator and the induction was
determined. TCPOBOP was used as the specific activator for the constitutive androstane
receptor and PCN for the pregnane X receptor. As shown in Fig. 1C, PCN generally induced
carboxylesterases to a greater extent than TCPOBOP (TCP) in neonatal mice with an
exception of ces2c. In adult mice, ces1d was induced to a slightly higher extent by TCP
whereas ces2e was induced to a slightly greater extent by PCN. Interestingly, TCP caused
much higher induction of ces2c than PCN in adult mice (Fig. 1C). These results suggest that
the magnitude of induction varies depending on age, receptor or a particular form of
carboxylesterases.
3.2. Isoform-specific induction of carboxylesterases at mRNA level
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We next tested whether the induction on the activity reflects increases of carboxylesterase
mRNA. Without exceptions, treatment with phenobarbital significantly increased the mRNA
levels of all six carboxylesterases in neonates (2.4- to 14.7-fold) (Fig. 2). In contrast, only
four of them were significantly induced in adult mice with the 4.9-fold induction being the
highest. Among all carboxylesterases, the magnitude of induction was greater in neonatal
than adult mice. At the basal levels, all carboxylesterases had higher levels of mRNA in
adult than neonatal mice with an exception of ces2e. The mRNA level of this
carboxylesterase in adult mice was lower than that in neonates, consistent with the activity
staining, particularly with 4-methylumbelliferylacetate as the substrate (Fig. 1). Based on the
Ct values (threshold cycles), the relative level of mRNA among these carboxylesterases
from the least to most abundance was: ces2c (30.2), ces1g (24.6), ces1e (24.3), ces2a (23.8),
ces1d (23.2) and ces2e (23.0) at basal expression.
3.3. Immunoreactivity of mouse carboxylesterases
We next examined whether the induction of mRNA translates into increases of protein. This
was determined by Western blotting. We did not have antibodies against all six
carboxylesterases. However, we raised several antibodies against human or rat
carboxylesterases in the past [15], and some of them were found to have high crossreactivity with other carboxylesterases [21, 23]. These antibodies were used to determine the
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levels of mouse liver carboxylesterases with recombinant enzymes as controls. As shown in
Fig. 3A, anti-human CES1 strongly cross-reacted with Ces1d. Anti-human CES2 strongly
cross-reacted with ces1e, modestly with ces2a and slightly with ces2e. These
carboxylesterases were electrophoretically distinct. As expected, anti-mouse ces1d showed
no cross-activity with other five carboxylesterases. Anti-rat ces1d strongly cross-reacted
with mouse ces1d and slightly with ces1g. Anti-rat ces1f slightly cross-reacted with mouse
ces1e. Anti-rat Ces1c strongly cross-reacted with ces1d and 1e, which were
electrophoretically distinct (Fig. 3A).
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As for the liver samples, anti-human CES1 detected two bands with the dominant band comigrating with ces1d (Fig. 3A). Based on the relative immune-staining, neonatal samples
showed a 1.96-fold induction whereas adult samples showed a 1.26-fold induction. Antihuman CES2 did not detect any carboxylesterases in liver samples, although this antibody
strongly cross-reacted with ces1e. Anti-mouse ces1d and anti-rat Ces1d detected similar
changes in neonates and adult as anti-human CES1 antibody. In contrast, anti-rat ces1f
detected a dominant carboxylesterase in adult but not neonatal samples, and this
carboxylesterase appeared not to be induced by phenobarbital. Anti-rat Ces1c antibody
detected a 2.26-fold induction of a carboxylesterase co-migrating with ces1d in neonatal
samples, but the same enzyme was induced by only 1.24 fold in adult samples. Clearly, the
Western blotting demonstrated that ces1d was induced to a higher extent in neonatal than
adult samples. Previously we have shown that human CES1, generally considered the
ortholog of mouse ces1d, hydrolyzed the antiplatelet agent clopidogrel but not aspirin [20].
To confirm whether greater induction of ces1d translates into higher hydrolytic activity by
neonatal samples, hydrolysis of clopidogrel and aspirin was determined. As shown in Fig.
3B, phenobarbital (PB) treatment significantly increased the hydrolysis of both agents by
neonatal samples. However, adult samples showed significant increases only in the
hydrolysis of clopidogrel. This increase was much higher in neonatal than adult samples
(5.8- versus 1.3-fold) (Fig. 3B).
3.4. Lipid accumulation and hydrolysis of aspirin, clopidogrel and 1-naphthylacetate
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As discussed above, the mouse genome has almost three times of the number of
carboxylesterase genes of the human genome [7]. It is conceivable that many mouse
carboxylesterases may share substrate specificity. To shed light on this possibility, lysates
from cells transfected with one of the six carboxylesterases was tested for the hydrolysis of
aspirin, clopidogrel and 1-naphythylacetate. As shown in Fig. 4A, transfection of ces2c and
ces2e but not others led to large increases in the hydrolysis of aspirin compared with vector
transfection. In contrast, transfection of ces1d but not others markedly increased the
hydrolysis of clopidogrel (Fig. 4B). Transfection of ces2c greatly increased the hydrolysis of
1-naphythylacetate (Fig. 4C). It should be noted that transfection of all carboxylesterases,
compared with vector transfection, caused statistically significant increases in the hydrolysis
of all three substrates. Several carboxylesterases, notably ces1d, were shown to hydrolyze
triglyceride [1]. To test this possibility, transfected cells were cultured in fatty acid-rich
medium and the lipid accumulation was determined by Oil Red O staining [24, 25]. As
shown in Fig. 5, transfection with ces1d but not others significantly increased the staining
intensity. This was surprising as ces1d is generally considered to hydrolyze triglyceride [1],
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thus favoring lipid elimination from cells. The same observation was made by microscopic
analysis (Right of Fig. 5). These results suggest that ces1d likely catalyzes synthesis of
triglyceride in fatty acid-rich condition.

4. Discussion
Hydrolytic metabolism is a major pharmacokinetic determinant of drugs containing such
functional groups as carboxylic acid ester, thioester and amide [2, 26, 27]. Previous studies
from this laboratory have suggested that both developmental and xenobiotic regulations are
involved in the expression of carboxylesterases [5, 11]. In this study, we tested the
inducibility of several major mouse carboxylesterases as a function of age: neonatal and
adult mice. The magnitude of the induction in neonates by phenobarbital was consistently
greater than that in their adult counterparts. In addition, the overall inducibility among
carboxylesterases varied markedly at mRNA level. The induction led to marked increases in
the hydrolysis of drugs such as clopidogrel, a widely used antiplatelet agent [19].
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The greater induction of carboxylesterases by phenobarbital during the developmental stage
likely represents a general phenomenon among various species. In rats, phenobarbital
induced several cytochrome P450 enzymes, however, the magnitude of the induction was
much higher in neonatal than adult animals [28]. Rufinamide, an antiepileptic agent, was
approved for treating seizures with Lennox-Gastaut syndrome in combination with other
antiepileptic drugs including phenobarbital [17]. Rufinamide caused little pharmacokinetic
changes in co-administered drugs, however, some of the co-administered drugs including
phenobarbital markedly decreased the plasma level of rufinamide [17]. The decrease in
pediatric patients was almost twice of that in adults. Given the fact that rufinamide
undergoes extensive hydrolytic metabolism, the greater decrease in pediatric patients is
likely due to greater induction of carboxylesterase, presumably CES1. On the other hand,
hydrolysis by carboxylesterases results in the formation of an alcohol and an acid [20, 29].
In many cases, the acid is removed by member-bound transporters. As a result, the
elimination of hydrolytic metabolites of drugs may vary depending on the relative changes
of the activities of particular transporters [30]. Interestingly, phenobarbital has been shown
to induce many transporters as well [31].
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In addition to a greater significance in drug-drug interactions, higher magnitude of induction
in children or young animals may have a greater effect on the development of metabolic
diseases. Many carboxylesterases are shown to hydrolyze lipids, presumably leading to
increased elimination of cellular lipids. Indeed, stable transfection of ces1g significantly
decreased the cellular accumulation of triglycerides [32]. Consistently, overexpression of
human CES1 through adenoviral transduction increased biliary elimination of cholesterol
[33]. On the other hand, knockout of ces1d, a major hydrolase of triglycerides, did not
increase steatotic phenotypes in the liver [34]. Likewise, transgenic expression of human
CES1 led to worsening lipid profile [35]. Clearly, more robust experimental approaches
should be taken to clarify these discrepancies. Nevertheless, many antiepileptic drugs
including phenobarbital were found to increase plasma total cholesterol and low-densitylipoprotein cholesterol in children [36]. Interestingly, the increase was not observed with
valproic acid, also a commonly used antiepileptic drug [37]. Valproic acid was recently
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found to inhibit human CES1 [37], pointing to an involvement of CES1 induction in the
increased plasma lipids.
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Phenobarbital is the most used antiepileptic worldwide [38] and represents the prototype of a
large number of structurally diverse inducers, commonly referred as to phenobarbital-type
inducers [39-41]. This antiepileptic exerts pharmacological activity by acting on the γaminobutyric acid receptors [38]. However, induction of drug-metabolizing enzymes and
transporters by phenobarbital is largely mediated through the activation of the constitutive
androstane receptor or the pregnane X receptor [22, 40]. These receptors are DNA sequencespecific transcription factors and share DNA binding activity to some extent. Nevertheless,
the study with receptor-specific activator suggested that both receptors likely support the
induction in response to phenobarbital but their involvement may varies depending on age
and the form of carboxylesterases (Fig. 1C). It should be noted that the inducibility of each
carboxylesterase was not necessarily associated with low basal level expression. For
example, ces1e and ces1g have similar basal expression based on the Ct values (24.3 versus
24.6), but a 2-fold induction was detected on ces1, whereas a 12-fold induction on ces1g
(Fig. 2). These findings suggest that phenobarbital uses multiple mechanisms (receptors) to
confer induction of carboxylesterases, and these mechanisms may not be equally involved in
the induction among various carboxylesterases.
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It was interesting to notice that carboxylesterases with a similar sequence identity did not
share similar substrate specificity. For example, ces1d, ces1e and ces1g share a sequence
identity of 74-78%, ces1d but not other two was highly active toward clopidogrel (Fig. 4B).
One explanation was the lower expression of ces1e and ces1g compared with ces1d. This
might not be true with ces1e as considerable expression of this carboxylesterase was
detected by Western blotting (Fig. 3A), although the immunostaining intensity on various
carboxylesterases depended on the relative affinities toward a cross-reactive antibody.
Likewise, ces2a, ces2c and ces2e share a sequence identity of 66-70%, and yet, only ces2c
and ces2e but not ces2a were highly active toward aspirin (Fig. 4A). Interestingly, ces2c was
highly induced by phenobarbital (Figs. 1 and 2E), but yet the hydrolysis of aspirin by lysates
from phenobarbital-treated mice was increased to a modest extent only (Left of Fig. 3B).
One explanation is that ces2c is one of many carboxylesterases with high aspirin hydrolytic
activity but other aspirin carboxylesterases were induced insignificantly. Nevertheless, the
substrate-specific experiment established that ces1d is highly active toward clopidogrel,
ces2c and ces2e are highly active toward aspirin and ces2c is highly active toward 1naphthylacetate (Fig. 4). We and other investigators have previously reported that human
CES1 preferably hydrolyze ester with an acid moiety relatively larger than the alcohol
moiety and the opposite is true with human CES2 [19, 27, 43]. In this regard, mouse ces1d
belongs to CES1 type of carboxylesterases, whereas ces2c and ces2e belong to CES2 type of
enzymes.
In summary, we have shown that inducibility of carboxylesterases was inversely related with
age. The higher induction translated into greater increases in the hydrolysis of commonly
used drugs. While this study used mouse as the model, the conclusions made in this report
are likely applicable to other species including humans. Phenobarbital induces many drugmetabolizing enzymes in a species-conserved manner, and we have shown that this
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antiepileptic drug induced human carboxylesterases in adult primary hepatocytes [15]. These
findings were also supported by clinical observations that drugs belonging to phenobarbitaltype inducers caused greater increases in the clearance of rufinamide and plasma lipids in
children. Overall, this study concludes that individuals in the developmental age experiences
greater changes in drug metabolism and lipid catabolism due to induction of
carboxylesterases.
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Abbreviation
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TCPOBOP

1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene

CES

carboxylesterase

DMEM

Dulbecco's modified eagle medium

GAPDH

glyceraldehyde-3-phosphate dehydrogenase

HPLC

High-performance liquid chromatography

IS

internal standard

PCN

pregnenolone 16α-carbonitrile

RT-qPCR

reverse transcription-quantitative polymerase chain reaction
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Fig. 1. Native-denaturing electrophoresis stained for hydrolytic activity of recombinant and
native carboxylesterases

NIH-PA Author Manuscript

(A) Activity staining with 1-naphthylacetate Lysate (10 μg) from carboxylesterasestransfected cells or liver homogenates (10 μg) from neonates (Neo) or adult mice treated
with saline or phenobarbital were subjected to native gel electrophoresis and stained for
esterase activity with 1-naphthylacetate as described in the section of Materials and
Methods. Liver homogenates were pooled from control (C) or phenobarbital (PB)-treated
mice (n = 4). (B) Activity staining with 4-methylumbelliferylacetate The experiment was
performed as same as that with 1-naphthylacetate but stained with 4methylumbelliferylacetate. (C) Activity staining with 4-methylumbelliferylacetate in
samples from TCPOBOP (TCP) or PCN (PCN)-treated mice Liver homogenates were
pooled from control (C), TCP or PCN-treated mice (n = 4) and analyzed for esterase activity
with 4-methylumbelliferylacetate as described above. The staining intensity was captured by
Carestream 2200 PRO Imager. This experiment was repeated four times.
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Fig. 2. Induction of carboxylesterase mRNA

Total liver RNA was isolated from mice treated with saline or phenobarbital (PB) and
analyzed by RT-qPCR for the mRNA level of ces1d (A), ces1e (B), ces1g (C), ces2a (D),
ces2c (E) and ces2e (F). Data were expressed as the mean ± SD. The numeric numbers
indicate the relative magnitude of induction and the asterisk sign denotes statistical
significance (P < 0.05).
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Fig. 3. Induction of carboxylesterase proteins

NIH-PA Author Manuscript

(A) Western blotting Lysate (10 μg) from carboxylesterases-transfected cells or liver
homogenates (10 μg) from neonates (Neo) or adult mice treated with saline or phenobarbital
were resolved by 7.5% SDS-PAGE and transferred electrophoretically to nitrocellulose
membranes. The blots were incubated with a carboxylesterase antibody and developed with
chemiluminescent substrate and re-probed by gapdh antibody. The signal was captured by
Carestream 2200 PRO Imager. The signals were normalized according to the signals from
gapdh. The ratios indicate the relative signals of phenobarbital (PB) treatment over control
(C). (B) Hydrolysis of aspirin and clopidogrel Enzyme incubations with S9 fraction (20 μg)
from individual livers (n = 4) were set up as described in Materials and Methods. The
incubation for aspirin hydrolysis lasted for 60 min whereas only 20 min for clopidogrel
hydrolysis. The formation of metabolites was determined by HPLC. Hydrolytic rates were
expressed as the mean ± SD (nmol or μmol/mg/min). The numeric numbers indicate the
magnitude of increased hydrolysis over controls and the asterisk sign denotes statistical
significance (P < 0.05).
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Fig. 4. Hydrolysis of aspirin, clopidogrel and 1-naphthylacetate by recombinant
carboxylesterases
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Cells (293T) were transfected with a carboxylesterase expression construct or the
corresponding vector. The transfected cells were cultured for 24 h and cell lysates were
prepared by sonication. Hydrolytic activity of cell lysates (20 μg) was determined toward
aspirin (A), clopidogrel (B) or 1-naphthylacetate (C). The hydrolysis of aspirin and
clopidogrel was monitored by HPLC whereas the hydrolysis of 1-naphthylacetate by
spectrophotometry from an increase in absorbance at 322 nm with 1 mM 1-naphthylacetate.
The results were collected from three separate experiments. The data are expressed as mean
± SE (standard error).
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Fig. 5. Lipid staining by Oil Red O
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Cells (293T) were transfected with a carboxylesterase expression construct or the
corresponding vector. The transfected cells were cultured for 24 h and then cultured in fatty
acid-rich medium. Cells were fixed and stained with Oil Red O as described in the section of
Materials and Methods by microscopic or spectrophotometric analyses. The data are
expressed as mean ± SE (standard error).
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